Viewing Study NCT05410418

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2026-06-05 @ 12:34 PM
Study NCT ID: NCT05410418
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-15
First Post: 2022-05-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma
Sponsor: Washington University School of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Follicular View
None Follicular Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None lymphoma View
None follicular lymphoma View
None antibody-drug conjugate View
None B-NHL View
None B cell non-Hodgkin lymphoma View
None mosunetuzumab View
None polatuzumab vedotin View
None bispecific antibody View